Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma

NCT00004110 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: monoclonal antibody 3F8
DRUG: etoposide
DRUG: isotretinoin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]